🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor grow...
Status
Completed
Location
Kantonspital Aarau
Start Date
2005-05
Trial ID
NCT00238290
Treatments Being Tested
This is an open-label, multicenter, Phase II study to evaluate the efficacy...
Status
Active Not Recruiting
Location
Research Site
Start Date
2024-02-22
Trial ID
NCT06271837
Treatments Being Tested
This is a prospective, multicenter, open-label, randomized, controlled Stud...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07417241
Treatments Being Tested
The goal of this clinical trial is to test ELVN-002 in people with cancers ...
Status
Active Not Recruiting
Location
University of Colorado - Anschutz Medical Campus - PPDS
Start Date
2023-03-20
Trial ID
NCT05650879
Treatments Being Tested
DESTINY-Gastric03 will investigate the safety, tolerability, pharmacokineti...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-06-03
Trial ID
NCT04379596
This study will evaluate the effectiveness of T-DXd in patients with HER2-p...
Status
Recruiting
Location
Research Site
Start Date
2025-09-18
Trial ID
NCT07124000
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This is a Phase 1 dose-finding study of FT536 given in combination with a m...
Status
Terminated
Location
Honor Health Research Institute
Start Date
2022-05-31
Trial ID
NCT05395052
Multiple trials confirm systemic T-DXd efficacy in HER2+ breast cancer with...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-04-18
Trial ID
NCT07134153
Treatments Being Tested
This is an open-label, single center, pilot study to assess the feasibility...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-31
Trial ID
NCT04757090
Treatments Being Tested